SAN ANTONIO – “Wow, what a year it has been,” said Dr. Larry Schlesinger, president and CEO of the Texas Biomedical Research Institute, about the ...
News
- Texas BioMed CEO reflects on its crucial role in vaccine development
- Histogen: Q4 Earnings Snapshot
The biotechnology company posted revenue of $478,000 in the period. For the year, the company reported that its loss widened to $18.8 million, ...
- Capricor: Q4 Earnings Snapshot
The biotechnology company posted revenue of $57,800 in the period. Its adjusted revenue was $58,000. For the year, the company reported that its ...
- Lineage Cell: Q4 Earnings Snapshot
The biotechnology company posted revenue of $355,000 in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $1.3 ...
- Ocular Therapeutix: Q4 Earnings Snapshot
The biotechnology company posted revenue of $7.3 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks ...